AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Accumulated-Depreciation" stands at 7.75 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
As of the end of AbbVie Inc's third quarter, the item "Accumulated Depreciation" stands at 7.75 Billion USD. This represents an increase of 1.24 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 8.52 percent compared to the value the year prior.
The 1 year change in percent is 8.52.
The 3 year change in percent is 33.87.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Accumulated Depreciation | 905,699,262,464.00 |
![]() | Johnson & Johnson - Accumulated Depreciation | 486,508,953,600.00 |
![]() | Roche Holding AG - Accumulated Depreciation | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Accumulated Depreciation | 280,205,508,085.11 |
![]() | Novartis AG - Accumulated Depreciation | 255,096,620,580.91 |